Piper Jaffray analyst, Tyler Van Buren reiterated his Overweight rating on shares of Biohaven Pharmaceutical Holding (NYSE: BHVN) and raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE